The Netherlands, Australia, New Zealand and the United States are consuming the highest amounts of designer 'party' drugs, according to wastewater samples taken from eight countries over the New Year period.
Feb 22, 2021
0
97
Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first ...
May 3, 2022
0
70
A monthly vaginal ring containing the antiretroviral drug dapivirine—an HIV prevention method that has been approved in several African countries and recommended by the World Health Organization (WHO) –appears to be safe ...
Feb 22, 2023
0
3
The Food and Drug Administration is considering approval of the first over-the-counter HIV test that would allow consumers to quickly test themselves for the virus at home, without medical supervision.
May 11, 2012
0
0
A chemical that has improved surgeries for brain cancer by making tumor cells fluorescent may also help doctors safely diagnose the disease and monitor its response to treatment, according to a new study led by investigators ...
Oct 15, 2019
0
5
Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the breadth of possibilities ...
Jun 24, 2024
0
26
A new paper in Rheumatology Advances in Practice indicates that granulomatosis with polyangiitis, a nasal disease that causes inflammation of the blood vessels and commonly presents with symptoms in sinuses, throat, lungs, ...
Apr 4, 2023
0
5
Patients with acute myeloid leukemia, the most common type of adult blood cancer, show large-scale genomic mutations and altered DNA folding patterns that could help identify potential therapeutic targets, according to a ...
Oct 28, 2022
0
34
Evidence of a relative to the bacteria that causes Lyme disease has been detected in human blood samples across New England, according to a new study led by researchers at the Yale School of Public Health.
Mar 24, 2022
1
231
Patients with non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitor sotorasib (Lumakras) had a two-year overall survival rate of 32.5 percent, according to data from the CodeBreaK 100 clinical trial presented ...
Apr 10, 2022
0
8
